) -- Shares of

Transition Therapeutics



) have taken a tremendous swing upward. The stock is trading at $4.80 as of 9:42 a.m. ET, 34.5% above Friday's closing price of $3.57. Volume is at 244,416, 2.5 times the daily average of 96,800.

Transition has a market cap of $82.9 million and is part of the

health care

sector and


industry. Shares are up 84% year to date as of the close of trading on Friday.

Transition Therapeutics Inc., a biopharmaceutical company, develops novel therapeutics for various disease indications primarily in Canada.

TheStreet Ratings rates Transition as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good. You can view the full

Transition Ratings Report


See our

top % gaining stocks list

for other stocks that are soaring today, or get investment ideas from our

investment research center